Pancreatic Disorders & Therapy
Open Access

Comprehensive Insights into Exocrine Pancreatic Function and Diagnostic Strategies

Amélie Bonnefond^{* *}Correspondence: Amélie Bonnefond, Department of Gastroenterology, Afe Babalola University, Ibadan, Nigeria, Email:

Author info »

Description

The pancreas, situated retroperitoneally and anatomically adjacent to the duodenum, fulfills bifunctional roles encompassing both the endocrine and exocrine systems pancreas, a important organ nestled behind the stomach, plays dual roles in the endocrine and exocrine systems. While the endocrine function involves hormone secretion into the bloodstream, regulating blood sugar levels, the exocrine function primarily concerns the production and secretion of digestive enzymes essential for food breakdown. This article delves into the intricacies of exocrine pancreatic function, disorders affecting it, and the diagnostic approaches employed in clinical settings.

Exocrine pancreatic function

The exocrine pancreas constitutes acinar cells responsible for producing enzymes important for the digestion of carbohydrates, proteins, and lipids [1]. These enzymes include amylase, lipase, and various proteases like trypsin, chymotrypsin, and elastase. Their synthesis initiates within the rough endoplasmic reticulum and progresses through the Golgi apparatus before storage in zymogen granules. Upon stimulation by hormonal and neural signals, these granules fuse with the apical membrane of acinar cells, releasing their contents into the pancreatic ducts [2].

Disorders affecting exocrine pancreatic function

Several conditions can disrupt exocrine pancreatic function, impacting digestion and nutrient absorption. Pancreatitis, characterized by inflammation of the pancreas, is a prominent disorder [3]. It can be acute, typically triggered by gallstones or alcohol consumption, or chronic, often linked with prolonged alcohol abuse or pancreatic duct obstruction. Cystic fibrosis, an inherited disorder affecting the CFTR gene, also impairs pancreatic enzyme secretion due to thickened secretions blocking ducts [4]. Exocrine Pancreatic Insufficiency (EPI) is another notable condition, marked by insufficient enzyme secretion to facilitate adequate digestion. It commonly arises from chronic pancreatitis, cystic fibrosis, pancreatic cancer, or pancreatic surgery. EPI manifests with symptoms like steatorrhea (fatty stools), weight loss, and malnutrition due to inadequate nutrient absorption [5].

Diagnosis of exocrine pancreatic disorders

Accurate diagnosis of exocrine pancreatic disorders is pivotal for timely intervention. Clinical evaluation often involves a combination of medical history assessment, physical examination, and diagnostic tests [6].

Blood tests: Serum levels of pancreatic enzymes, including amylase and lipase, are routinely measured. Elevated levels suggest pancreatic inflammation or injury, aiding in pancreatitis diagnosis [7].

Imaging studies: Various imaging modalities offer insights into pancreatic structure and function. Abdominal ultrasound, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) can visualize pancreatic abnormalities, such as inflammation, cysts, or tumors [8].

Endoscopic procedures: Endoscopic Retrograde Cholangio- pancreatography (ERCP) allows direct visualization of the pancreatic ducts and biliary tree, facilitating the diagnosis of pancreatic duct obstruction, strictures, or stones.

Stool studies: Stool tests measuring fecal elastase-1 levels provide a non-invasive means to assess pancreatic function. Reduced elastase-1 levels indicate pancreatic insufficiency, aiding in EPI diagnosis.

Functional tests: Pancreatic function tests, like the secretin stimulation test, assess the pancreas's ability to secrete bicarbonate and digestive enzymes in response to stimulation. These tests offer valuable insights into pancreatic function and aid in diagnosing EPI.

Conclusion

The exocrine pancreas plays a vital role in digestion, synthesizing and secreting enzymes essential for nutrient breakdown. Disorders affecting exocrine pancreatic function, such as pancreatitis, cystic fibrosis, and exocrine pancreatic insufficiency, pose significant health challenges, necessitating accurate diagnosis and management. With a comprehensive understanding of exocrine pancreatic function and the diagnostic modalities available, healthcare professionals can effectively identify and address exocrine pancreatic disorders, improving patient outcomes and quality of life.

References

1. Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(1):254-272.

   [Crossref] [Google Scholar] [PubMed]

2. Khan A, Vege SS, Dudeja V, Chari ST. Staging exocrine pancreatic dysfunction. Pancreatology. 2022;22(1):168-172.

   [Crossref] [Google Scholar] [PubMed]

3. Lankisch PG, Schreiber A, Otto J. Pancreolauryl test: evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Digestive diseases and sciences. 1983; 28:490-493.

   [Crossref] [Google Scholar] [PubMed]

4. Walkowiak J, Cichy WK, Herzig KH. Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis. Scandinavian journal of gastroenterology. 1999;34(2):202-207.

   [Crossref] [Google Scholar] [PubMed]

5. Capurso G, Traini M, Piciucchi M, Signoretti M, Arcidiacono PG. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clinical and experimental Gastroenterology. 2019:129-139.

   [Crossref] [Google Scholar] [PubMed]

6. Carrière F, Grandval P, Renou C, Palomba A, Priéri F, Giallo J, et al. Quantitative study of digestive enzyme secretion and gastrointestinal lipolysis in chronic pancreatitis. Clinical Gastroenterology and Hepatology. 2005;3(1):28-38.

   [Crossref] [Google Scholar] [PubMed]

7. Colclough K, Ellard S, Hattersley A, Patel K. Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of maturity-onset diabetes of the young. Diabetes. 2022;71(3):530-507. [Crossref]

   [Google Scholar] [PubMed]

8. Sikkens EC, Cahen DL, van Eijck C, Kuipers EJ, Bruno MJ. The daily practice of pancreatic enzyme replacement therapy after pancreatic surgery: a northern European survey. Journal of Gastrointestinal Surgery. 2012;16(8):1487-1492.

   [Crossref] [Google Scholar] [PubMed]